StonvexLoading…
StonvexStonvexStonvexCore line items from KTOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $418.90M | $371.00M | $1.35B | $1.00B | $654.10M |
Operating Income | Not available | $4.70M | $25.60M | $17.40M | $10.30M |
Net Income | Not available | $11.90M | $22.00M | $16.10M | $7.40M |
EPS (Diluted) | $0.15 | $0.07 | $0.13 | $0.10 | $0.05 |
Total Assets | Not available | $4.04B | $2.47B | $2.42B | $2.59B |
Total Liabilities | Not available | $632.70M | $470.90M | $441.80M | $625.70M |
Cash & Equivalents | Not available | $1.46B | $560.60M | $565.90M | $783.60M |
Free Cash Flow OCF − CapEx | Not available | $-47.30M | $-137.40M | $-125.30M | $-84.00M |
Shares Outstanding | Not available | 187.39M | 168.88M | 168.84M | 168.56M |